Ligand profile
FRL
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04428 — Adenosine deaminase
Identifiers
Database identifiers and provenance.
- Ligand ID
FRL- PDB
1wxz- UniProt (similar protein)
P56658- Target protein
- KP13_04428
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 107.2
- −1 ≤ LogP ≤ 5 4.00
- MW ≤ 500 Da 424.9
- LogP ≤ 5 4.00
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 107.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@@H](C(CCc1cccc2c1oc(n2)c3ccc(cc3)Cl)n4cc(nc4)C(=O)N)OC[C@@H](C(CCc1cccc2c1oc(n2)c3ccc(cc3)Cl)n4cc(nc4)C(=O)N)O
InChI=1S/C22H21ClN4O3/c1-13(28)19(27-11-18(21(24)29)25-12-27)10-7-14-3-2-4-17-20(14)30-22(26-17)15-5-8-16(23)9-6-15/h2-6,8-9,11-13,19,28H,7,10H2,1H3,(H2,24,29)/t13-,19?/m0/s1InChI=1S/C22H21ClN4O3/c1-13(28)19(27-11-18(21(24)29)25-12-27)10-7-14-3-2-4-17-20(14)30-22(26-17)15-5-8-16(23)9-6-15/h2-6,8-9,11-13,19,28H,7,10H2,1H3,(H2,24,29)/t13-,19?/m0/s1
SMFRBBHLVBWHGB-YTJLLHSVSA-NSMFRBBHLVBWHGB-YTJLLHSVSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00962
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand FRL →
- PDB RCSB structure 1wxz →
- UniProt UniProt P56658 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “FRL”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04428.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).